Stada Arzneimittel AG’s recent acquisition spree is continuing as the German firm’s private-equity backers seek to bolster its footprint in the growth markets of Eastern Europe.
The company said it was poised to become a major player in Ukraine through the acquisition of Biopharma’s pharmaceutical prescription...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?